N-[[1-[6-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]-4,4-difluoro-5-methylpiperidin-3-yl]methyl]methanesulfonamide;4-[6-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]morpholine-2-carboxamide;N-[[1-[6-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]piperidin-3-yl]methyl]methanesulfonamide;[3-[6-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]piperidin-1-yl]-(1-methylpyrazol-4-yl)methanone;6-(difluoromethyl)-3-[6-[1-(2-methylsulfonylethyl)piperidin-3-yl]pyrimidin-4-yl]imidazo[1,2-b]pyridazine

C93H99F12N35O9S3 — CID 158608804

IUPACN-[[1-[6-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]-4,4-difluoro-5-methylpiperidin-3-yl]methyl]methanesulfonamide;4-[6-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]morpholine-2-carboxamide;N-[[1-[6-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]piperidin-3-yl]methyl]methanesulfonamide;[3-[6-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]piperidin-1-yl]-(1-methylpyrazol-4-yl)methanone;6-(difluoromethyl)-3-[6-[1-(2-methylsulfonylethyl)piperidin-3-yl]pyrimidin-4-yl]imidazo[1,2-b]pyridazine
SMILESCC1CN(c2cc(-c3cnc4ccc(C(F)F)nn34)ncn2)CC(CNS(C)(=O)=O)C1(F)F.CS(=O)(=O)CCN1CCCC(c2cc(-c3cnc4ccc(C(F)F)nn34)ncn2)C1.CS(=O)(=O)NCC1CCCN(c2cc(-c3cnc4ccc(C(F)F)nn34)ncn2)C1.Cn1cc(C(=O)N2CCCC(c3cc(-c4cnc5ccc(C(F)F)nn45)ncn3)C2)cn1.NC(=O)C1CN(c2cc(-c3cnc4ccc(C(F)F)nn34)ncn2)CCO1
InChIInChI=1S/C21H20F2N8O.C19H21F4N7O2S.C19H22F2N6O2S.C18H21F2N7O2S.C16H15F2N7O2/c1-29-10-14(8-27-29)21(32)30-6-2-3-13(11-30)16-7-17(26-12-25-16)18-9-24-19-5-4-15(20(22)23)28-31(18)19;1-11-8-29(9-12(19(11,22)23)6-27-33(2,31)32)17-5-14(25-10-26-17)15-7-24-16-4-3-13(18(20)21)28-30(15)16;1-30(28,29)8-7-26-6-2-3-13(11-26)15-9-16(24-12-23-15)17-10-22-18-5-4-14(19(20)21)25-27(17)18;1-30(28,29)24-8-12-3-2-6-26(10-12)17-7-14(22-11-23-17)15-9-21-16-5-4-13(18(19)20)25-27(15)16;17-15(18)9-1-2-13-20-6-11(25(13)23-9)10-5-14(22-8-21-10)24-3-4-27-12(7-24)16(19)26/h4-5,7-10,12-13,20H,2-3,6,11H2,1H3;3-5,7,10-12,18,27H,6,8-9H2,1-2H3;4-5,9-10,12-13,19H,2-3,6-8,11H2,1H3;4-5,7,9,11-12,18,24H,2-3,6,8,10H2,1H3;1-2,5-6,8,12,15H,3-4,7H2,(H2,19,26)
InChIKeyHWOLUVCHNSUXKG-UHFFFAOYSA-N
MW2175.23 g/mol
LogP10.31
Rot. Bonds26

About N-[[1-[6-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]-4,4-difluoro-5-methylpiperidin-3-yl]methyl]methanesulfonamide;4-[6-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]morpholine-2-carboxamide;N-[[1-[6-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]piperidin-3-yl]methyl]methanesulfonamide;[3-[6-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]piperidin-1-yl]-(1-methylpyrazol-4-yl)methanone;6-(difluoromethyl)-3-[6-[1-(2-methylsulfonylethyl)piperidin-3-yl]pyrimidin-4-yl]imidazo[1,2-b]pyridazine

N-[[1-[6-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]-4,4-difluoro-5-methylpiperidin-3-yl]methyl]methanesulfonamide;4-[6-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]morpholine-2-carboxamide;N-[[1-[6-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]piperidin-3-yl]methyl]methanesulfonamide;[3-[6-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]piperidin-1-yl]-(1-methylpyrazol-4-yl)methanone;6-(difluoromethyl)-3-[6-[1-(2-methylsulfonylethyl)piperidin-3-yl]pyrimidin-4-yl]imidazo[1,2-b]pyridazine (PubChem CID 158608804) has the molecular formula C93H99F12N35O9S3 and a molecular weight of 2175.23 g/mol. Its IUPAC name is N-[[1-[6-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]-4,4-difluoro-5-methylpiperidin-3-yl]methyl]methanesulfonamide;4-[6-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]morpholine-2-carboxamide;N-[[1-[6-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]piperidin-3-yl]methyl]methanesulfonamide;[3-[6-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]piperidin-1-yl]-(1-methylpyrazol-4-yl)methanone;6-(difluoromethyl)-3-[6-[1-(2-methylsulfonylethyl)piperidin-3-yl]pyrimidin-4-yl]imidazo[1,2-b]pyridazine.

Molecular Properties

Compound NameN-[[1-[6-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]-4,4-difluoro-5-methylpiperidin-3-yl]methyl]methanesulfonamide;4-[6-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]morpholine-2-carboxamide;N-[[1-[6-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]piperidin-3-yl]methyl]methanesulfonamide;[3-[6-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]piperidin-1-yl]-(1-methylpyrazol-4-yl)methanone;6-(difluoromethyl)-3-[6-[1-(2-methylsulfonylethyl)piperidin-3-yl]pyrimidin-4-yl]imidazo[1,2-b]pyridazine
PubChem CID158608804
Molecular FormulaC93H99F12N35O9S3
Molecular Weight2175.23 g/mol
Exact Mass2173.73
IUPAC NameN-[[1-[6-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]-4,4-difluoro-5-methylpiperidin-3-yl]methyl]methanesulfonamide;4-[6-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]morpholine-2-carboxamide;N-[[1-[6-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]piperidin-3-yl]methyl]methanesulfonamide;[3-[6-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]piperidin-1-yl]-(1-methylpyrazol-4-yl)methanone;6-(difluoromethyl)-3-[6-[1-(2-methylsulfonylethyl)piperidin-3-yl]pyrimidin-4-yl]imidazo[1,2-b]pyridazine
SMILESCC1CN(c2cc(-c3cnc4ccc(C(F)F)nn34)ncn2)CC(CNS(C)(=O)=O)C1(F)F.CS(=O)(=O)CCN1CCCC(c2cc(-c3cnc4ccc(C(F)F)nn34)ncn2)C1.CS(=O)(=O)NCC1CCCN(c2cc(-c3cnc4ccc(C(F)F)nn34)ncn2)C1.Cn1cc(C(=O)N2CCCC(c3cc(-c4cnc5ccc(C(F)F)nn45)ncn3)C2)cn1.NC(=O)C1CN(c2cc(-c3cnc4ccc(C(F)F)nn34)ncn2)CCO1
InChIInChI=1S/C21H20F2N8O.C19H21F4N7O2S.C19H22F2N6O2S.C18H21F2N7O2S.C16H15F2N7O2/c1-29-10-14(8-27-29)21(32)30-6-2-3-13(11-30)16-7-17(26-12-25-16)18-9-24-19-5-4-15(20(22)23)28-31(18)19;1-11-8-29(9-12(19(11,22)23)6-27-33(2,31)32)17-5-14(25-10-26-17)15-7-24-16-4-3-13(18(20)21)28-30(15)16;1-30(28,29)8-7-26-6-2-3-13(11-26)15-9-16(24-12-23-15)17-10-22-18-5-4-14(19(20)21)25-27(17)18;1-30(28,29)24-8-12-3-2-6-26(10-12)17-7-14(22-11-23-17)15-9-21-16-5-4-13(18(19)20)25-27(15)16;17-15(18)9-1-2-13-20-6-11(25(13)23-9)10-5-14(22-8-21-10)24-3-4-27-12(7-24)16(19)26/h4-5,7-10,12-13,20H,2-3,6,11H2,1H3;3-5,7,10-12,18,27H,6,8-9H2,1-2H3;4-5,9-10,12-13,19H,2-3,6-8,11H2,1H3;4-5,7,9,11-12,18,24H,2-3,6,8,10H2,1H3;1-2,5-6,8,12,15H,3-4,7H2,(H2,19,26)
InChIKeyHWOLUVCHNSUXKG-UHFFFAOYSA-N
XLogP10.31
TPSA509.74 Ų
H-Bond Donors3
H-Bond Acceptors40
Rotatable Bonds26
Heavy Atoms152
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002175.23
LogP ≤ 510.31
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 1040

Analyze N-[[1-[6-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]-4,4-difluoro-5-methylpiperidin-3-yl]methyl]methanesulfonamide;4-[6-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]morpholine-2-carboxamide;N-[[1-[6-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]piperidin-3-yl]methyl]methanesulfonamide;[3-[6-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]piperidin-1-yl]-(1-methylpyrazol-4-yl)methanone;6-(difluoromethyl)-3-[6-[1-(2-methylsulfonylethyl)piperidin-3-yl]pyrimidin-4-yl]imidazo[1,2-b]pyridazine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[[1-[6-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]-4,4-difluoro-5-methylpiperidin-3-yl]methyl]methanesulfonamide;4-[6-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]morpholine-2-carboxamide;N-[[1-[6-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]piperidin-3-yl]methyl]methanesulfonamide;[3-[6-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]piperidin-1-yl]-(1-methylpyrazol-4-yl)methanone;6-(difluoromethyl)-3-[6-[1-(2-methylsulfonylethyl)piperidin-3-yl]pyrimidin-4-yl]imidazo[1,2-b]pyridazine?
The IUPAC name of N-[[1-[6-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]-4,4-difluoro-5-methylpiperidin-3-yl]methyl]methanesulfonamide;4-[6-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]morpholine-2-carboxamide;N-[[1-[6-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]piperidin-3-yl]methyl]methanesulfonamide;[3-[6-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]piperidin-1-yl]-(1-methylpyrazol-4-yl)methanone;6-(difluoromethyl)-3-[6-[1-(2-methylsulfonylethyl)piperidin-3-yl]pyrimidin-4-yl]imidazo[1,2-b]pyridazine (CID 158608804) is N-[[1-[6-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]-4,4-difluoro-5-methylpiperidin-3-yl]methyl]methanesulfonamide;4-[6-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]morpholine-2-carboxamide;N-[[1-[6-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]piperidin-3-yl]methyl]methanesulfonamide;[3-[6-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]piperidin-1-yl]-(1-methylpyrazol-4-yl)methanone;6-(difluoromethyl)-3-[6-[1-(2-methylsulfonylethyl)piperidin-3-yl]pyrimidin-4-yl]imidazo[1,2-b]pyridazine.
What is the SMILES notation for N-[[1-[6-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]-4,4-difluoro-5-methylpiperidin-3-yl]methyl]methanesulfonamide;4-[6-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]morpholine-2-carboxamide;N-[[1-[6-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]piperidin-3-yl]methyl]methanesulfonamide;[3-[6-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]piperidin-1-yl]-(1-methylpyrazol-4-yl)methanone;6-(difluoromethyl)-3-[6-[1-(2-methylsulfonylethyl)piperidin-3-yl]pyrimidin-4-yl]imidazo[1,2-b]pyridazine?
The canonical SMILES for N-[[1-[6-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]-4,4-difluoro-5-methylpiperidin-3-yl]methyl]methanesulfonamide;4-[6-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]morpholine-2-carboxamide;N-[[1-[6-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]piperidin-3-yl]methyl]methanesulfonamide;[3-[6-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]piperidin-1-yl]-(1-methylpyrazol-4-yl)methanone;6-(difluoromethyl)-3-[6-[1-(2-methylsulfonylethyl)piperidin-3-yl]pyrimidin-4-yl]imidazo[1,2-b]pyridazine is CC1CN(c2cc(-c3cnc4ccc(C(F)F)nn34)ncn2)CC(CNS(C)(=O)=O)C1(F)F.CS(=O)(=O)CCN1CCCC(c2cc(-c3cnc4ccc(C(F)F)nn34)ncn2)C1.CS(=O)(=O)NCC1CCCN(c2cc(-c3cnc4ccc(C(F)F)nn34)ncn2)C1.Cn1cc(C(=O)N2CCCC(c3cc(-c4cnc5ccc(C(F)F)nn45)ncn3)C2)cn1.NC(=O)C1CN(c2cc(-c3cnc4ccc(C(F)F)nn34)ncn2)CCO1.
What is the InChIKey of N-[[1-[6-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]-4,4-difluoro-5-methylpiperidin-3-yl]methyl]methanesulfonamide;4-[6-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]morpholine-2-carboxamide;N-[[1-[6-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]piperidin-3-yl]methyl]methanesulfonamide;[3-[6-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]piperidin-1-yl]-(1-methylpyrazol-4-yl)methanone;6-(difluoromethyl)-3-[6-[1-(2-methylsulfonylethyl)piperidin-3-yl]pyrimidin-4-yl]imidazo[1,2-b]pyridazine?
The InChIKey is HWOLUVCHNSUXKG-UHFFFAOYSA-N. The full InChI is InChI=1S/C21H20F2N8O.C19H21F4N7O2S.C19H22F2N6O2S.C18H21F2N7O2S.C16H15F2N7O2/c1-29-10-14(8-27-29)21(32)30-6-2-3-13(11-30)16-7-17(26-12-25-16)18-9-24-19-5-4-15(20(22)23)28-31(18)19;1-11-8-29(9-12(19(11,22)23)6-27-33(2,31)32)17-5-14(25-10-26-17)15-7-24-16-4-3-13(18(20)21)28-30(15)16;1-30(28,29)8-7-26-6-2-3-13(11-26)15-9-16(24-12-23-15)17-10-22-18-5-4-14(19(20)21)25-27(17)18;1-30(28,29)24-8-12-3-2-6-26(10-12)17-7-14(22-11-23-17)15-9-21-16-5-4-13(18(19)20)25-27(15)16;17-15(18)9-1-2-13-20-6-11(25(13)23-9)10-5-14(22-8-21-10)24-3-4-27-12(7-24)16(19)26/h4-5,7-10,12-13,20H,2-3,6,11H2,1H3;3-5,7,10-12,18,27H,6,8-9H2,1-2H3;4-5,9-10,12-13,19H,2-3,6-8,11H2,1H3;4-5,7,9,11-12,18,24H,2-3,6,8,10H2,1H3;1-2,5-6,8,12,15H,3-4,7H2,(H2,19,26).
What are the key properties of N-[[1-[6-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]-4,4-difluoro-5-methylpiperidin-3-yl]methyl]methanesulfonamide;4-[6-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]morpholine-2-carboxamide;N-[[1-[6-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]piperidin-3-yl]methyl]methanesulfonamide;[3-[6-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]piperidin-1-yl]-(1-methylpyrazol-4-yl)methanone;6-(difluoromethyl)-3-[6-[1-(2-methylsulfonylethyl)piperidin-3-yl]pyrimidin-4-yl]imidazo[1,2-b]pyridazine?
N-[[1-[6-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]-4,4-difluoro-5-methylpiperidin-3-yl]methyl]methanesulfonamide;4-[6-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]morpholine-2-carboxamide;N-[[1-[6-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]piperidin-3-yl]methyl]methanesulfonamide;[3-[6-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]piperidin-1-yl]-(1-methylpyrazol-4-yl)methanone;6-(difluoromethyl)-3-[6-[1-(2-methylsulfonylethyl)piperidin-3-yl]pyrimidin-4-yl]imidazo[1,2-b]pyridazine has a molecular weight of 2175.23 g/mol, XLogP of 10.31, 26 rotatable bonds, 3 hydrogen bond donors, and 40 hydrogen bond acceptors.
Where does this data come from?
All data for N-[[1-[6-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]-4,4-difluoro-5-methylpiperidin-3-yl]methyl]methanesulfonamide;4-[6-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]morpholine-2-carboxamide;N-[[1-[6-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]piperidin-3-yl]methyl]methanesulfonamide;[3-[6-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]piperidin-1-yl]-(1-methylpyrazol-4-yl)methanone;6-(difluoromethyl)-3-[6-[1-(2-methylsulfonylethyl)piperidin-3-yl]pyrimidin-4-yl]imidazo[1,2-b]pyridazine is sourced from PubChem (CID 158608804), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).